Phibro Animal Health (NASDAQ:PAHC – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 1.040-1.160 for the period, compared to the consensus estimate of 1.100. The company issued revenue guidance of $980.0 million-$1.0 billion, compared to the consensus revenue estimate of $999.0 million.
Phibro Animal Health Price Performance
NASDAQ:PAHC traded up $0.41 during trading hours on Wednesday, reaching $17.18. 130,110 shares of the company’s stock were exchanged, compared to its average volume of 152,202. The company has a market capitalization of $695.79 million, a P/E ratio of 47.72, a price-to-earnings-growth ratio of 6.30 and a beta of 0.63. Phibro Animal Health has a 12 month low of $9.40 and a 12 month high of $17.44. The business’s 50-day simple moving average is $13.39 and its two-hundred day simple moving average is $12.00. The company has a quick ratio of 1.60, a current ratio of 3.12 and a debt-to-equity ratio of 1.66.
Phibro Animal Health (NASDAQ:PAHC – Get Free Report) last released its quarterly earnings data on Wednesday, February 7th. The company reported $0.33 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.06. The business had revenue of $249.90 million during the quarter, compared to analyst estimates of $242.91 million. Phibro Animal Health had a return on equity of 16.67% and a net margin of 1.51%. Sell-side analysts expect that Phibro Animal Health will post 1.12 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Read Our Latest Stock Analysis on PAHC
About Phibro Animal Health
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Stories
- Five stocks we like better than Phibro Animal Health
- Market Cap Calculator: How to Calculate Market Cap
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- The 3 Best Fintech Stocks to Buy Now
- Generac Powers Ahead on the Electrification Mega-Trend
- Dividend Capture Strategy: What You Need to Know
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.